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Ileal pouch-anal anastomosis was an important advancement in the treatment of ulcerative colitis. The aim of this study
was to determine whether early complications of ileal pouch-anal anastomosis in patients with ulcerative colitis are associated
with poor late functional results.
PATIENTS AND METHODS: Eighty patients were operated on from 1986 to 2000, 62 patients with ileostomy and 18
without. The early and late complications were recorded. Specific emphasis has been placed on the incidence of pouchitis
with prolonged follow-up.
RESULTS: The ileostomy was closed an average of 9.2 months after the first operation. Fourteen patients were
excluded from the long-term evaluation; 6 patients were lost to regular follow-up, 4 died, and 4 patients still have the
ileostomy. Of the 4 patients that died, 1 died from surgical complications. Early complications after operation (41) occurred
in 34 patients (42.5%). Late complications (29) occurred in 25 patients as follows: 16 had pouchitis, 3 associated with
stenosis and 1 with sexual dysfunction; 5 had stenosis; and there was 1 case each of incisional hernia, ileoanal fistula,
hepatic cancer, and endometriosis. Pouchitis occurred in 6 patients (9.8%) 1 year after ileal pouch-anal anastomosis, 9
(14.8%) after 3 years, 13 (21.3%) after 5 years, and 16 (26.2%) after more than 6 years. The mean daily stool frequency was
12 before and 5.8 after operation. One pouch was removed because of fistulas that appeared 2 years later.
CONCLUSIONS: Ileal pouch-anal anastomosis is associated with a considerable number of early complications.
There was no correlation between pouchitis and severe disease, operation with or without ileostomy, or early postoperative
complications. The incidence of pouchitis was directly proportional to duration of time of follow-up.
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The development of the ileal
pouch-anal anastomosis (IPAA) tech-
nique was an important advancement
in the treatment of ulcerative colitis.
Total colectomy cures the
gastrointestinal symptoms and elimi-
nates the risk of cancer, and the ileal
pouch-anal anastomosis preserves
anorectal functions. This procedure is
now widely accepted and because of
its advantages has been increasingly
performed in most patients with ulcera-
tive colitis. Surgical treatment is being
indicated sooner and more frequently.
Many of these patients are young with
a long life expectancy. Patient satisfac-
tion with the procedure is high
(73.3%)1,2 . However, patients may ex-
perience various episodic or continu-
ous symptoms. We have observed that
postoperative complications even
when the operations were performed by
highly qualified surgeons were not
negligible, and in the long-term fol-
low-up, the results were not as good as
expected.
The aim of this study was to deter-
mine whether early complications of
IPAA in patients with ulcerative coli-
tis are associated with poor late func-
tional results. Specific emphasis has
been placed on the incidence of
pouchitis with prolonged follow-up.
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PATIENTS AND METHODS
Eighty patients underwent IPAA
from 1986 to 2000. Forty patients were
female. The mean age of first symp-
toms was 26.6 years.
The average time between first
symptoms and diagnosis was 1.4 years
and between first symptoms and opera-
tion was 4.8 years. Diagnosis was
based on clinical, endoscopic, and his-
topathological criteria. Mean follow-
up was 9.0 years. Two hundred opera-
tions were performed, an average of 2.5
operations / patient. The surgical pro-
cedure consisted of abdominal
proctocolectomy and construction of
a 15 cm ileal J-pouch using staplers or
hand-sewn (first 9 cases). All patients
had preoperative bowel preparation
and all received antibiotics.
Thirty-one patients had a colec-
tomy and ileostomy performed previ-
ously. Later on, 26 underwent IPAA,
receiving a J-shaped ileal pouch with
ileostomy, and 5 without ileostomy.
Forty-nine patients underwent
IPAA, with ileostomy in 36 and with-
out in 13. The ileostomy was closed
9.2 months on average after the first
operation.
All peri-operative complications as
well as early (within 1 month) and late
(more than 1 month) complications af-
ter discharge from hospital were re-
corded. All complications, even small
ones and not procedure-related, were
recorded. Information was obtained re-
garding bowel function, anal conti-
nence, abdominal pain, and need for
drugs before and after surgical treat-
ment. Minor incontinence was defined
as the presence of spotting on under-
wear at least once a week.
The diagnosis of pouchitis was
made based on clinical, endoscopic,
and histological manifestations. Clini-
cal evaluation included the length of
time between IPAA and the first epi-
sode of pouchitis, the number of epi-
sodes (one, multiple, or chronic), and
the result of treatment.
Fourteen patients were excluded
from the long-term evaluation: 6 pa-
tients were lost to regular follow-up;
4 died; and 4 still have the ileostomy
(1 of whom refuses closure for personal
reasons).
At each consultation, every 6
months, the patient’s recent history
was recorded and he or she underwent
a clinical and endoscopic examination.
Random biopsy was taken only in
cases of clinically suspected pouchitis.
STATISTICS
Comparisons of proportions were
made with the χ2 test. Values of less




Four patients died. One death was
caused by surgical complications. Two
patients died of cancer, 1 hepatic and
1 colonic. One patient died from
causes not related to ulcerative colitis
or its surgical treatment.
Postoperative morbidity
EARLY COMPLICATIONS
Thirty-four patients (42.5%) pre-
sented 41 complications after IPAA .
The following early complications
related to the J-pouch were diagnosed:
7 leakages of pouch-anal anastomosis
(11.5%), 2 were re-operated, 1 of which
resulted in death with pelvic sepsis; 4
subcutaneous wound infections; 4 in-
testinal obstructions (6.5%) handled
conservatively; and 1 each of the fol-
lowing vaginal secretion (for more
than a month), fever of unknown
etiology, cerebral vascular accident
and bleeding requiring reoperation.
The total number of ileostomies
constructed was 68 including 62 IPAA
with ileostomies and 6 performed for
treatment of leakage, 4 after ileostomy
closure and 2 after IPAA without ileos-
tomy. The following early complica-
tions related to ileostomy were diag-
nosed: ileostomy disfunction and der-
matitis. Fourteen patients had compli-
cations after the ileostomy closure: 1
had a subcutaneous wound infection;
5 had anastomotic leakage; and 8 had
an intestinal obstruction, 1 of whom
underwent reoperation.
Five patients with anastomotic
leakage after ileostomy closure under-
went reoperation, and 4 new ileosto-
mies were performed and successfully
closed later on. One patient underwent
intestinal resection and suture. He pre-
sented an incisional hernia that re-
quired surgical correction.
Six of 18 patients undergoing
IPAA without ileostomy presented
early complications (33.3%). Anasto-
motic leakage occurred in 2 patients
(11.1%) requiring reoperation with
construction of a defunctioning loop
ileostomy that was closed later on.
Two patients presented with perianal
dermatitis, 1 with urinary retention
and 1 with an intestinal obstruction.
LATE COMPLICATIONS
Twenty-five patients presented
29 late complications: 16 had
pouchitis, 3 associated with stenosis
and 1 with sexual dysfunction; 5 had
stenosis; and 1 each had incisional
hernia, ileoanal fistula 2 years after
creation of the J-pouch, hepatic can-
cer, and endometriosis.
Seventeen patients who had a
defunctioning ileostomy presented the
following late complications: 11 had
pouchitis, 5 had stenosis, and 1 each
had ileo-anal fistula, hernia, endome-
triosis, and sexual dysfunction. The
fistula appeared 2 years after IPAA ,
and the pouch was excised 6 years af-
ter IPAA surgery.
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Table 1 - Early postoperative complications and pouchitis.
Pouchitis
Postoperative complications n (%)   n (%) Total
With Without
With 9 (13.6) 17 (25.8) 26 (39.4)
Without 7 (10.6) 33 (50.0) 40 (60.6)
Total 16 50 66 (100)
p = 0.113
Table 2 - Incidence of pouchitis and the ileal pouch-anal anastomosis with or
without ileostomy.
Pouchitis
Ileostomy n (%)    n (%) Total
With Without
With 11 (16.7) 39 (59.0) 50
Without 5 (7.6) 11 (16.7)  16
Total  16 50 66 (100%)
p = .452
Seven patients of the 16 undergo-
ing IPAA without ileostomy presented
8 late complications: 5 had pouchitis
and 3 had stenosis. The stenosis were
treated successfully by anal dilatation.
There was no statistically signifi-
cant association regarding frequency
of complications and the performance
or not of ileostomy during the IPAA
surgery. (p = 0.592).
Pouchitis
Pouchitis occurred in 16 patients
an average 36.5 months after the clo-
sure of the ileostomy (range 1 to 72
months). It was acute in 8 patients and
chronic in 8. There were 7 patients who
underwent the IPAA surgery with a
toxic megacolon; none developed
pouchitis.
The association of postoperative
complications and pouchitis were
analyzed (Table 1). The χ2 test did not
show strong statistical evidence of as-
sociation between the variables (p =
0.113).
We compared the incidence of
pouchitis and the IPAA surgery with or
without ileostomy (Table 2). There was
no statistical evidence of association
between the variables (p = 0.452).
Six patients had pouchitis 1 year
after IPAA (9.8%), 9 (14.8%) after 3
years, 13 (21.3%) after 5 years, and 16
(26.2%) after more than 6 years.
Pouch failure
One pouch was removed because
of fistulas that appeared 2 years after
IPAA. The fistulas were not responsive
to any kind of treatment. There was no
sign of Crohn’s disease, and after re-
moval of the pouch the patient become
asymptomatic.
Stool frequency and continence
The mean daily stool frequency
was 12 before and 5.8 after IPAA.
Sixty-two percent reported a decrease
of the mean stool frequency from 14
to 6, 23.4% had an increase from 6 to
9, and 14.1% had no change. Minor
anal incontinence was reported by 2
patients before and 6 after IPAA.
Other symptoms and need for medi-
cation
Bleeding was reported by 47 of pa-
tients before and 10 after IPAA, and
abdominal pain was reported by 41
before and 12 after IPAA. All patients
except 1 received medication before
surgical treatment. After IPAA, 32
needed medication occasionally as fol-
lows: 17 were medicated with metro-
nidazole, 14 with ciprofloxacin, 14
with steroids, 4 with azathioprine, and
3 with sulfasalazine/5-ASA.
DISCUSSION
Ileal pouch-anal anastomosis has
become the method of choice for the
surgical treatment of ulcerative colitis.
Initially, we performed a loop ileos-
tomy in all patients. Loop ileostomy
is associated with complications, is
difficult to manage, requires the use of
expensive bags, and requires a second
operation for closure with potential
morbidity. We practice at a state hos-
pital with a long queue of patients
awaiting hospitalization, explaining
the long interval between the con-
struction of ileostomy and its closure.
Based on the experience of others3,4
we decided to use a covering ileos-
tomy selectively only for patients
thought to have an increased risk of
anastomotic leakage. Preoperative use
of high doses of steroids was not a for-
mal indication to perform an ileos-
tomy.
Another important aspect concern-
ing defunctioning ileostomy is that of
the 7 anastomotic leaks that occurred
after IPAA in the ileostomy group, 2
patients needed reoperation, and 1
died. Therefore, the ileostomy did not
prevent pelvic sepsis, probably due to
error of construction. On the other
hand, 2 patients undergoing IPAA
without ileostomy needed a second
surgery for treatment of leakage. Since
the use of ileostomy was not
randomized but was a conscious option
of the surgeon, we believe that if it had
not been performed, the number of
complications would have been
higher. An increasing number of sur-
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geons are performing this operation
without ileostomy2,5,6. Mowschenson
et al.2 performed 78.5% of their IPAA
procedures without ileostomy, with
9.8% of cases with anastomotic leak-
age requiring a diverting stoma. In our
experience, the possibility of perform-
ing IPAA without ileostomy was the
opposite (22.8%), with a similar per-
centage of leakage (11.1%). The prob-
lem is how to determine which pa-
tients should have or not have an il-
eostomy. Even if we knew, it is impor-
tant that the patient and his or her fam-
ily accept the risk of an anastomotic
leak requiring additional surgery, and
with a high possibility of having the
pouch removed in the follow-up with
creation of a permanent ileostomy.
Morbidity in this series was high,
probably because patients with indica-
tion for surgery had extensive disease;
most of them were undernourished,
anemic, and using medication that
causes immunosuppression.
Mortality rate related to surgery
was low (1.25%). These data are in
agreement with other reports7,8. Of the
3 deaths in the late follow-up, 2 pa-
tients died of cancer, 1 of which was
colonic. It is well known that patients
with ulcerative colitis are at an in-
creased risk for development of carci-
noma of the colon and rectum.
Whether to perform IPAA in patients
with carcinoma complicating ulcera-
tive colitis is not entirely clear based
on the literature9. We indicate the pro-
cedure as long as a radical cancer sur-
gery is possible to perform in patients
with a relatively favorable long-term
prognosis from cancer based on stage
and grade9,10 and in patients whose
pouches will not be exposed to subse-
quent radiation therapy11.
Ileal pouch-anal anastomosis is a
technically demanding operation that
can be associated with serious compli-
cations. The number of patients with
early complications was high (34 =
42.5%), but only 10 (12.5%) needed a
second operation. Nevertheless, our
data show that IPAA with or without
ileostomy is associated with elevated
incidence of early complications and
should be performed only in special-
ized centers.
Pouch-anal anastomotic stricture
was more frequent in the group under-
going IPAA without (31.3%) than with
(4.7%) ileostomy and was easily cor-
rected by digital dilatation in every
case.
Anal dilatation required in
transanal mucosectomy in hand-sewn
IPAA or the transection of bowel at the
transitional zone damaging the inter-
nal sphincter in stapled IPAA imply a
risk of incontinence. It was considered
as a minor disability by our patients.
The infrequency of anal irritation is
also a reflection of good continence
and minimal stool leakage.
Small bowel obstruction is ob-
served frequently before ileostomy clo-
sure and remains a potential problem
after closure8. In our experience, 69%
of the 13 cases occurred after ileos-
tomy closure. According to Meagher et
al.8, the number of patients suffering an
episode of small bowel obstruction
following IPAA will increase for up to
10 years after operation, as might be




Only one pouch was excised in this
series.
Pouchitis was the most frequent
late complication and clearly related
to a worse outcome. It was directly pro-
portional to the length of follow-up.
The etiology of pouchitis remains
unknown. Possible causes are fecal sta-
sis resulting in bacterial overgrowth
and infection12, microbial imbalance13,
production of volatile fatty acids14,15,
ischemia14, oxygen free radical in-
jury16, nitric oxide17, deprivation of
short chain fatty acids18,19, and
extracolonic manifestation of ulcera-
tive colitis. Penna et al.20 reported a
strong correlation between primary
sclerosing cholangitis and pouchitis,
suggesting a common link in their
pathogenesis. Teixeira et al.21 showed
that pouchitis was more frequent in
patients with extra-intestinal manifes-
tations.
The reported rates of prevalence of
pouchitis in patients undergoing sur-
gery for ulcerative colitis vary between
5%22 and 47%23.
Acute pouchitis was more frequent
(21.3%) than chronic pouchitis (4.9%),
as described by others22,24,25. Penna et
al.21 reported a cumulative risk of de-
veloping pouchitis 1, 2, 5, and 10
years after IPAA of 16%, 23%, 36%,
and 46%, respectively. Luukkonen et
al.22 found a cumulative risk of 50% at
4 years and a 7 % at 6 years. Heuschen
et al.24 reported a cumulative risk of
50% of pouchitis at 8 years after IPAA.
Yu et al.26 found after 10 years of fol-
low-up an overall incidence of any
complication of 48%, 50% of these
due to pouchitis.
There was no correlation between
pouchitis and early postoperative
complications.
Pouchitis was more frequent in the
group undergoing IPAA without ileos-
tomy, and we do not know how to ex-
plain this finding. The correlation be-
tween complications after operation
and incidence of pouchitis was ex-
pected but not statistically significant.
Patients that experience complications
in general are the ones with more ex-
tensive and severe disease, and
pouchitis could be accepted as an
extracolonic manifestation of ulcera-
tive colitis. To what extent the pres-
ence of extraintestinal manifestations
should influence the choice of surgi-
cal treatment is not clear. Further stud-
ies are required to address this issue7.
Patients should be informed with
details of the consequences of the IPAA
procedure by the surgeon to avoid high
expectations. Many patients hope that
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after the operation they will be abso-
lutely normal with the same quality of
life they had before developing ulcera-
tive colitis. Our data show that some-
times the results can be disappointing.
The mean stool frequency of our pa-
tients after IPAA is similar to the de-
scribed by other authors8. Even in those
patients with a decreased rate of evacu-
ations, the average number is higher
than the expected in a normal person.
In 37.5% of the patients, the mean stool
frequency did not change or even in-
creased. Concerning other symptoms,
such as abdominal pain and bleeding,
results were better, but 29.5% and
25.5% respectively showed no im-
provement. Six patients (9.8%) still ex-
perienced minor incontinence, which is
a small number in our estimation. But
it is important to remember that some
patients experienced an eventual epi-
sode of major incontinence, very excep-
tional to be considered in this paper but
enough to make the patient lose confi-
dence for several months.
Clinical intractability is the main
indication for surgical treatment.
Therefore, patients expect to stop tak-
ing medication after the operation, but
52.5% of our patients needed sporadic
or continuous medical treatment be-
cause of pouchitis or pouch dysfunc-
tion. Ileal pouch-anal anastomosis
without ileostomy is relatively safe if
the patient and the family clearly ac-
cept the risk of an early postoperative
anastomotic leakage2.
There is still the risk of neoplastic
transformation in the pouch, mainly in
cases of chronic pouchitis27,28 or in the
remaining anal mucosa. Ileal pouch-
anal anastomosis requires regular sur-
veillance24.
CONCLUSIONS
1. Ileal pouch-anal anastomosis is as-
sociated with a considerable
number of early complications.
There was no correlation between
pouchitis and early postoperative
complications.
2. Pouchitis was directly proportional
to the length of follow-up. Severe
disease was not associated with
pouchitis.
3. Ileal pouch-anal anastomosis is the
surgical therapy of choice for pa-
tients with ulcerative colitis, but
the patient should be informed of
the possibility of the eventual
need for the use of medications af-
ter the operation, of unsatisfactory
functioning of the pouch, and the
possibility of late complications,
including removal of the pouch.
RESUMO
TEIXEIRA MG e col. - Resultado pre-
coce e tardio da anastomose íleo-
anal com reservatório ileal na
retocolite ulcerativa. Rev. Hosp.
Clín. Fac. Med. S. Paulo 58(4):
193-198, 2003.
A anastomose íleo-anal com reser-
vatório ileal foi um importante avan-
ço no tratamento da retocolite ulce-
rativa. O objetivo deste trabalho foi
determinar se os maus resultados fun-
cionais tardios estariam relacionados às
complicações precoces da anastomose
íleo-anal com reservatório ileal em do-
entes com retocolite ulcerativa.
MATERIAL E MÉTODO: Oiten-
ta doentes foram operados entre 1986
e 2000, 60 com ileostomia de prote-
ção e 18 sem. Os doentes foram avali-
ados quanto a incidência de compli-
cações pós-operatórias precoces e tar-
dias. Enfatizou-se a incidência de bol-
site no pós-operatório prolongado.
RESULTADO: A ileostomia foi fe-
chada em média 9,2 meses após a pri-
meira operação. Quatorze doentes fo-
ram excluídos da avaliação tardia: seis
perderam o seguimento e quatro fale-
ceram. Quatro doentes permanecem
com a ileostomia. Trinta e quatro do-
entes (42,5%) apresentaram 41 compli-
cações precoces. Vinte e cinco apresen-
taram 29 complicações tardias: 16
bolsites, três associadas a estenose e
uma a disfunção erétil; cinco esteno-
ses e uma de cada das seguintes: hér-
nia incisional, fístula íleoanal, câncer
hepático e endometriose. Seis doentes
apresentaram bolsite um ano após a
anastomose íleoanal com reservatório
ileal (9,8%), nove (14,8%) após três
anos, 13 (21,3%), após cinco anos e 16
(26,2%) após seis anos.A freqüência
diária média de evacuação era de 12
antes e de 5,8 após a operação.Um re-
servatório foi removido devido ao apa-
recimento de fístulas dois anos depois.
CONCLUSÃO: A anastomose íleo-
anal com reservatório ileal está asso-
ciada com número considerável de
complicações. Não há correlação entre
bolsite e doença grave, operação com
ou sem ileostomia ou complicações
pós-operatórias imediatas. A incidên-
cia de bolsite foi diretamente propor-
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